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Brief CommunicationsA modified and simplified radiofrequency ablation in
patients with mitral valve disease
Roland Fasol, MD,a Johann Meinhart, PhD,a and Thomas Binder, MD,b Vienna, AustriaTo eliminate atrial fibrillation (AF) in patients with mitralvalve disease, the Cox maze procedure has been con-comitantly performed. However, because it is an exten-sive and complex “cut and sew” technique, the proce-
dure is complex to perform. As a consequence, easier to apply
ablation methods were introduced that restore sinus rhythm (SR)
and atrial contraction (AC) in more than 70% of treated patients.1
This has resulted in controversial discussions concerning the best
possible ablation line patterns.
We have now modified, simplified, and reduced the currently
applied complex saline-irrigated, cooled-tip radiofrequency abla-
tion (SICTRA)1 procedure to a simple, effective, quick, and “easy-
to-apply” procedure in 10 consecutive patients (50% were male,
mean age 66.3  9.3 years) with excellent results at a 1-year
follow-up.
Patients and Methods
In 2002, 10 consecutive patients with mitral valve disease and
chronic AF (preexisting 6 months) had their mitral valve re-
paired. Valvular disease was degenerative in 8 patients and is-
chemic in 2 patients.
Surgery. The details of mitral repair are listed in Table 1. The
applied SICTRA set-up technique (Medtronic, Inc, Minneapolis,
Minn) was previously published.1 Our modified and simplified
“triangle-like” lesion pattern, isolating the right and left pulmonary
veins as well as the suture-closed orifice of the left atrial append-
age (not resected) and meeting at the midportion of the posterior
mitral annulus, is described in detail in Figure 1.
From the Department of Cardiovascular Surgery,a Hospital Lainz, and
Department of Cardiology,b AKH, University of Vienna, Vienna, Austria.
Received for publication March 7, 2004; accepted for publication April 6,
2004.
Address for reprints: Roland Fasol, MD, IMC-International Innovative
Medical Care Center, Krustettnerstrasse, A-3506 Krems/Hollenburg,
Austria (E-mail: rfasol@imc-hospital.com).
J Thorac Cardiovasc Surg 2005;129:215-7
0022-5223/$30.00
Copyright © 2005 by The American Association for Thoracic Surgery
See related editorial on page 1.doi:10.1016/j.jtcvs.2004.04.022
The Journal of ThoraciPostoperative care. There was no specific protocol for this
group of patients concerning medication or pacing, which differed
from the usual hospital routine.
Follow-up. Patient data were obtained perioperatively, at the
time of discharge from the hospital, 1 month postoperatively after
discharge from the rehabilitation clinic, and at the time of the
follow-up in September of 2003 (16.4  3.2 months, range 11-20
months). A medical history, clinical examination, and electrocar-
diogram were obtained at each visit. A transthoracic echocardio-
gram, including pulsed-wave Doppler of transmitral flow, was
obtained at the time of follow-up.
Results
There were no early or late deaths. All patients were in SR when
they were weaned from bypass. Four patients required periopera-
Figure 1. Intraoperative view of the left atrium showing suture
closure of the left atrial appendage and simple “triangle-like”
ablation lines, isolating the right and left pulmonary veins (as
well as the suture-closed orifice of the left atrial appendage) and
meeting at the midportion of the posterior mitral annulus.
Dr Fasoltive pacemaker stimulation, beca
c and Cardiovascular Surgery ●use the heart rate was below 65
Volume 129, Number 1 215
Brief Communicationsbeats/min, and 3 patients required postoperative cardioversion.
Follow-up was 100% complete. The results of echocardiographic
evaluation showed normal function of the repaired mitral valve in
all patients. Rhythm was evaluated by electrocardiogram and
Holter monitoring and detection of an A wave (AC) by Doppler
echocardiography.
During follow-up, 6 patients received antiarrhythmic medica-
tions by their general practitioners (2 patients received type II
antiarrhythmics [amiodarone] and 4 patients received beta block-
ers [metoprolol]). At the time of follow-up, 90% were in New
York Heart Association functional class I or II. All patients de-
scribed their quality of life as significantly improved compared
with their preoperative quality of life. Only 3 patients were kept on
antiarrhythmic medications (2 patients received beta blockers, and
1 patient received type II antiarrhythmics). There were no late
cardiac-related reoperations or other complications. At the time of
follow-up, all but 2 patients were in continuous and stable SR.
These 2 patients received warfarin sodium (Coumadin). One pa-
tient required a pacemaker because of intermittent SR bradycardia,
and 1 patient had occasional periods of intermittent AF. Never-
theless, a hemodynamic relevant AC was well documented in all
patients (Figure 2).
Discussion
The motivation to perform this pilot study was to assess the
possible effectiveness of a simple and “easy-to-apply” technique to
interrupt macro-reentry circles to eliminate AF in patients with
mitral valve disease, because the authors judged the currently
available ablation techniques as too time-consuming and often too
difficult or “uncomfortable” to perform. Therefore, our mean
crossclamp time of 42 minutes was comparable with that reported
in other studies (103 minutes1 and 99 minutes2). Furthermore,
Figure 2. Pulsed wave Doppler spectrum across the m
The presence of a distinct A-wave documents hemody
A, atrial contraction.because reports of possible complications such as atrial-esopha-
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bolism started to surface, we explored a less invasive, simpler, and
safer technique to avoid such complications.3,4 We demonstrated
that our simple “triangle-like” ablation lines (Figure 1) met all the
essential requirements to eliminate AF; are simple, easy, and quick
to perform; are obviously not hampered by some of the reported
possible complications; and effectively eliminated AF in every
patient up to the present.
The idea behind our concept of a simplified SICTRA tech-
nique was also to reduce the amount of atrial tissue being
“destroyed” (ablated) and subsequently reducing the time re-
quired to perform this technique. We are convinced that the
postoperative function of the left atrium and its subsequent
hemodynamic relevant AC may correlate to the amount of left
atrial tissue being damaged or ablated. Our results therefore
also showed a hemodynamic relevant AC in every patient,
although the result in one of our patients is limited by occa-
sional incidences of intermittent AF. In contrast, AC, or hemo-
dynamic relevant atrial activity, was shown to be present in
66% to 91%1,5 of all treated patients and was not even assessed
in other studies.2 Furthermore, we did not resect the left atrial
appendage; the orifice was suture closed to avoid possible
bleeding complications. We also did not use a right atrial
ablation, because the expected incidence of AF recurrence
caused by foci from the right atrium is approximately only 10%
to 14%.5
Conclusion
It may be assumed that our modified and simplified ablation
technique proved to be effective and showed promising results.
However, larger patient numbers and a longer follow-up will be
required to prove the long-term effectiveness of this modified
valve in a patient after the modified maze procedure.
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Preoperative and postoperative echochardiographic parameters
Characteristics Preoperative
LA (mm) 55.4 6.8
LVED (mm) 65.2 5.1
LVES (mm) 43.5 3.9
CABG, Coronary artery bypass graft; TVR, tricuspid valve repair; LA, left atr
polytetrafluoroethylene.
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Inhaled nitric oxide does not improve systemic oxygenation after
bidirectional superior cavopulmonary anastomosisel, MD,a Boston, Mass, and Toronto, Ontario, CanadaInhaled nitric oxide (NO) is a selective pulmonary vasodilatorthat decreases intrapulmonary shunt fraction.1 We sought todetermine whether inhaled NO would ameliorate hypoxemiaafter bidirectional superior cavopulmonary anastomosis
(BCPA).
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The research and ethics review board approved the study, and the
parents of all children gave informed and written consent. We
included patients with systemic oxygen saturations of 75% or less
after BCPA without venous decompressing collaterals or pulmo-
nary disease. Patients were mechanically ventilated and studied on
the first postoperative day in the intensive care unit. From a stable
baseline, patients received a 15-minute trial of inhaled NO (80
ppm).2 During the trial of inhaled NO, ventilator parameters and
FIO2 were unchanged. In 5 patients, cyclic guanosine monophos-
phate (cGMP) levels were measured.2 One patient first received
inhaled NO in the cardiac catheterization laboratory because of
persistent hypoxemia after coil embolization of decompressing
venous collaterals. This same patient was readmitted 7 months
after BCPA with refractory hypoxemia as the result of respiratory
syncytial viral pneumonitis and was treated with 10 ppm NO.
Statistical Analysis
A paired Student t test with a Bonferroni correction for 3 compar-
isons was used. The difference between cGMP levels was com-ial; LVpared by the nonparametric Wilcoxon signed-rank test.
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